What Does Schedule III Rescheduling Actually Change for Operators?

The single biggest change is tax, not legality. Jon Purow of Greenspoon Marder made the case in 2023, in Emergency NY Update, Unknown Impact of Cannabis Rescheduling & IP Protection ft. Jon Purow: under Schedule III, 280E no longer applies, operators can deduct normal business expenses, and he put that at potentially up to a 30% profitability boost. That is the number operators should anchor on. Everything else is slower and messier.

Signed is not the same as done

The executive order came in December 2025, and the Dime covered it that day in Schedule III Changes Everything, This Is Just the Beginning with Zach Edge and Matt of RHO Advisory and Madron Process Development. Matt was direct about what it did and did not do: "None of this has actual rules in it yet, it's all guidance for other people to come up with rules." He said it has to go through rulemaking at DOJ, FDA, DEA and HHS. What the episode described was the start of a process, not a finished one, and operators should check where that rulemaking stands before planning around it.

It also does not open interstate commerce for marijuana. Matt said hemp products can already move interstate, but the marijuana side can't, and he didn't expect medical licenses to get leeway there either. If they did, he said, FDA approved players might push to stop it, because interstate operation as a federally licensed facility is one of their advantages over state licensed operators.

Supply chain operators carry the compliance weight

Brands are not where the pressure lands first. Zach said supply chain operators, meaning growers and extraction and purification operators, have the most to work through, because the rulemaking affects them most. The order discusses GMP manufacturing, and 21 CFR Part 211 is specific about what pharmaceutical GMP requires. Zach said state programs approximate it to varying degrees but none fully meet it, particularly in QC and QA, track and trace, and downstream monitoring. Matt called compounding pharmacies probably the number one new entrants. The same episode described removing quotas and relaxing research access as a route to much better data.

What Schedule III doesn't touch

Erin Moffet of The Liaison Group laid out the limits in 2024 in Behind the Scenes of Cannabis Lobbying. Rescheduling doesn't provide banking access, so safe banking is still needed. Moving from Schedule I to Schedule III doesn't even change how most people are charged, so criminal justice reform is still needed. And it doesn't address regulatory structure, how to maintain a safe, regulated market.

For an operator, the practical read is this. Model the 280E relief, but do not book it until the rules are final and in effect. Do not assume banking, interstate shipping or a national license structure arrive on the same timeline. Those are separate fights, and none of them is won by the order alone.